NEW YORK (GenomeWeb News) – Dutch molecular diagnostics company GenDx announced today that Qiagen has granted it non-exclusive rights for the worldwide distribution for Qiagen's LongRange PCR kit in combination with GenDx's SBTexcellerator reagents for high-resolution HLA typing.
The agreement covers both direct distribution by GenDx as well as third-party distribution.
The combination of the LongRange PCR kit and SBTexcellerator reagents allows researchers to amplify HLA genes beyond the exon 2, 3, and 4 regions, making it possible to identify by sequencing other important regions of HLA genes, GenDx said.
"This distribution agreement enables GenDx and [its] partners to even better fulfill the requirements of our customers worldwide to efficiently obtain reliable HLA-typing results," Wietse Mulder, managing director for GenDx, said in a statement.
SBTexcellerator reagents received CE Marking in September for high-resolution HLA typing. GenDx and Qiagen have an ongoing collaboration to develop and commercialize products for HLA testing, and Qiagen is the exclusive worldwide distributor for the SBT reagent line.